Risk factor
Very poor trading liquidity
Profitability factor
Excellent dividends
About
Li Kang Biomedical Co., Ltd. specializes in the development and distribution of nutritional supplements, cosmeceuticals, and health-focused beverages. Beyond its product lines, the company also provides consulting and operational support for tourism factories, and offers telemarketing solutions. Established in 1982, the firm initially operated under the name BAFO Technologies Corporation, before adopting its current moniker, Li Kang Biomedical Co., Ltd., in September 2014. The company maintains its headquarters in Tainan City, Taiwan.
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair valu
Target Price
The average target price of 6242.TWO is 162 and suggests 377% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in